Transformation in site monitoring practices through risk based monitoring
As the current trends in clinical trial industry, is evolving day by day and adopting upcoming technology to integrate data from different sources into risked based monitoring (RBM) Portal, to increase efficient tracking system in a way that help in understanding site characteristic and make on-site monitoring visit more focused and accurate. Transformation from traditional monitoring method to RBM solution will significantly improve quality of data and will also reduce study risk and time. RBM is a standardized, systematic approach to identify and assess potential risk.
Oversight of Clinical Investigations. A Risk-Based Approach to Monitoring. FDA – Guidance for Industry. 2013. Available at http://www.fda.gov/
ScienceResearch/SpecialTopics/RunningClinicalTrials/GuidancesInformationSheetsandNotices/ucm219433.htm. Accessed on August 2013.
Reflection paper on risk based quality management in clinical trials. TransCelarate. 2013. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/11/WC500155491.pdf. Accessed on 18 August 2013.
TransCelerate Position Paper: Risk based monitoring Methodology Final. TransCelarate. 2016. Available at http://www.transceleratebiophar
mainc.com/assets/risk-based-monitoring. Accessed on 10 February 2016.
Clinical Trial Transformation Initiative. 2015. Available at http://www.ctti-clinicaltrials.org/what-we-do/study-conduct/monitoring. Accessed on 31 Dec 2015.
Cognizant’s Clinical Transformation - Life sciences solution overview. Cognizant. 2012. Available at https://www.cognizant.com/life-sciences/clinical-transformation-services. Accessed on 1 July 2016.
Transform clinical development through advances in risk-based monitoring. Quintiles. 2015. Available at http://www.quintiles.com/library/white-papers/
transform-clinical-development-through-advances-in-risk-based-monitoring. Accessed on 30 May 2016.
Risk-adapted Approaches to the Management of Clinical Trials of Investigational. MHRA Forum. 2013. Available at http://www.risk- adapted_appro
aches_to_the_management_of_clinical_trials_of_investigational_medicinal_products.pd. Accessed on 30 March 2016.
Changes to regulators monitoring guidelines, rationale and update. MHRA. 2014. Available at https://www.gov.uk/guidance/clinical-trials-for-med
es. Accessed on 12 July 2016.
Risk Assessment Is the Foundation of Risk-Based Monitoring. InVentiv Health. 2014. Available at http://www.inventivhealth.com/pdf/Seeing_Around_Corners_and_3a_Risk_Assessment_Is_The_Foundation_of_Risk_Based_Monitoring.pdf. Accessed on 10 August 2016.
How Companies Can Make the Most of Their Early Drug Development Stage. MPI Research. 2015. Available at http://www.contractpharma.com/csd/
/11600. Accessed on 31 December 2015.
Model Approach for Risk-Based Monitoring. TransCelerate. 2013. Available at http://www.transc
f. Accessed on 30 May 2016.
Guidance Webinar Video, Transcript from FDA Webinar Session. 2012. Available at http://www.fda
gov/Training/GuidanceWebinars/ucm276211.htm. Accessed on 31 Dec 2016.
Guidance on Risk-Proportionate Approaches to the Management and Monitoring of Clinical Trials, Medicines and Healthcare Products Regulatory Agency. 2011. Available at http://trialsjournal.biom
dcentral.com/articles/10.1186/1745-6215-15-127. Accessed on 31 December 2015.
Guidance for Industry Oversight of Clinical Investigations: A Risk Based Approach to Monitoring (Draft Guidance). U.S. Food & Drug Administration. 2011. Available at http://www.fda.
gov/downloads/ScienceResearch/SpecialTopics/CriticalPathInitiative/UCM277529.pdf. Accessed on 31 December 2015.
Malcolm Frank. Don’t Get SMACked: How Social, Mobile, Analytics and Cloud Technologies are Reshaping the Enterprise. Cognizant Technology Solutions. 2012. Available at https://www.cognizant com/InsightsWhitepapers/dont-get-smacked.pdf. Accessed on 31 March 2015.